| Preface | |
| Pt. I | Leukemia Overview | |
| Ch. 1 | Living with Leukemia: What You Need to Know | 3 |
| Ch. 2 | Leukemia Facts and Figures | 15 |
| Ch. 3 | Risk Factors for Leukemia | 25 |
| Ch. 4 | Diagnosing Adult Acute Leukemia | 29 |
| Ch. 5 | Understanding Blood Cell Counts | 37 |
| Ch. 6 | Bone Marrow Aspiration and Biopsy | 43 |
| Ch. 7 | How to Find a Doctor or Treatment Facility | 49 |
| Ch. 8 | Clinical Trials: Questions and Answers | 63 |
| Ch. 9 | Moving Toward a New Understanding of Leukemia | 75 |
| Ch. 10 | How to Find Resources in Your Own Community If You Have Leukemia | 85 |
| Ch. 11 | Financial Issues for People with Cancer | 91 |
| Pt. II | Childhood Leukemia | |
| Ch. 12 | Childhood Acute Lymphoblastic Leukemia | 111 |
| Ch. 13 | Childhood Acute Myeloid leukemia and Acute Promyelocytic Leukemia | 129 |
| Ch. 14 | Statistics of Childhood Leukemia | 157 |
| Ch. 15 | Procedures That Diagnose and Treat Children with Leukemia | 165 |
| Ch. 16 | Guidelines for Parents of Children with Leukemia | 179 |
| Ch. 17 | Helping Children Understand Clinical Trial Participation | 189 |
| Ch. 18 | Blood Counts and Record Keeping | 197 |
| Ch. 19 | Interactions with Friends When a Child Has Leukemia | 205 |
| Pt. III | Adult Leukemia | |
| Ch. 20 | Pre-Leukemia Myelodysplastic Syndrome (MDS) | 217 |
| Ch. 21 | Acute Lymphocytic Leukemia (ALL) | 223 |
| Ch. 22 | Chronic Lymphocytic Leukemia (CLL) | 235 |
| Ch. 23 | Acute Myelogenous Leukemia (AML) | 249 |
| Ch. 24 | Chronic Myelogenous Leukemia (CML) | 265 |
| Ch. 25 | Hairy Cell Leukemia | 279 |
| Pt. IV | Leukemia Treatments | |
| Ch. 26 | Understanding Drug Therapy and Managing Side Effects | 287 |
| Ch. 27 | Radiation Therapy for Cancer Treatment | 309 |
| Ch. 28 | Transplantation Therapy for Leukemia | 327 |
| Ch. 29 | Gleevec: Newest Treatment for CML | 371 |
| Ch. 30 | Targeting Treatment in AML | 381 |
| Ch. 31 | What's New in Adult Acute Lymphocytic Leukemia Research and Treatment? | 387 |
| Ch. 32 | Azacytidine for Patients with Pre-Leukemia | 391 |
| Ch. 33 | Using the Immune System to Treat Leukemia | 393 |
| Ch. 34 | Complementary and Alternative Therapies for Leukemia | 401 |
| Ch. 35 | Access to Investigational Drugs | 413 |
| Pt. V | Life during and after Treatment for Leukemia | |
| Ch. 36 | Cancer Survivor's Treatment Record | 421 |
| Ch. 37 | Nutrition in Cancer Care | 427 |
| Ch. 38 | Neutropenic Diet | 451 |
| Ch. 39 | Fatigue and Leukemia Treatment | 459 |
| Ch. 40 | Pain Control with Leukemia Treatment | 465 |
| Ch. 41 | Long-Term and Late Effects of Leukemia Treatments | 477 |
| Ch. 42 | Minimal Residual Disease: Gauging the Risk of Leukemia Relapse | 485 |
| Ch. 43 | Support for People with Cancer and the People Who Care about Them | 489 |
| Pt. VI | Additional Help and Information | |
| Ch. 44 | Glossary of Important Leukemia-Related Terms | 503 |
| Ch. 45 | Directory of Additional Resources on Leukemia | 511 |
| Ch. 46 | Directory of Prescription Drug Assistance Programs for People with Leukemia | 517 |
| Ch. 47 | Financial Assistance for People with Leukemia | 531 |
| Index | 541 |
loading...